ArticleJournal for immunotherapy of cancer2024

Preclinical evaluation of antigen-sensitive B7-H3-targeting nanobody-based CAR-T cells in glioblastoma cautions for on-target, off-tumor toxicity.

Fien Meeus et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.